American Diabetes Association 67th Scientific Sessions – San Francisco—June 2008
Thanks to a generous grant from the Simon Wolff Charitable Foundation I was able to attend the American Diabetes association 67th Annual Scientific Sessions in San Francisco, California. I had been fortunate enough to have my work accepted for a poster presentation at the meeting.
The ADA meeting is the highlight of the diabetes year. It allows all those working in diabetes research around the globe to meet and discuss their work and ideas. My poster presented my work in the field of estimating life expectancy in type 2 diabetes. This is an important are and some of my previous work has highlighted the inequalities in annuity payments made to people with diabetes compared to those without diabetes.
During the poster sessions I was able to discuss my findings with individuals from both Europe and the United States and it was great to get their feedback on my work.
The highlight of this year’s meeting was the presentation of three large scale clinical trials investigating the association between glucose control and cardiovascular disease-the ADVANCE, ACCORD and VADT trials. Being able to listen to the results first hand and then listen as world leaders critiqued the results was a fantastic experience and has allowed me to form my own ideas about how I will translate the results of these studies into my clinical practice for the benefit of the patients I care for. I also attended many of the sessions relating to exercise and physical activity as my current work is now focusing on motivating physical activity and other lifestyle changes in individuals with diabetes with the aim of reducing their cardiovascular disease risk.
Whilst in San Francisco I was able to spend some time seeing the sights and I found the golden gate bridge breathtaking and was lucky enough to see it in all its glory without any surrounding fog. The city is vibrant and exciting with an eclectic mix of cultures and people.
I have returned from the conference with a renewed enthusiasm for my work and with plenty of new ideas. I would like to thank the Simon Wolf Charitable Trust once again for supporting me and my work and allowing me to attend such an important scientific meeting.
Dr Hermione Price
Clinical Research Fellow
Diabetes Trials Unit
University of Oxford